机构:[1]Biomedical Pioneering Innovation Center, School of Life Sciences, Ministryof Education Key Laboratory of Cell Proliferation and Differentiation,Beijing 100871, China[2]State Key Laboratory of Cardiovascular Disease, FuwaiHospital, National Center for Cardiovascular Diseases, Chinese Academyof Medical Sciences and Peking Union Medical College, Beijing 100871,China[3]Beijing Advanced Innovation Center for Genomics, Peking University,Beijing 100871, China[4]Peking‑Tsinghua Center for Life Sciences, Academyfor Advanced Interdisciplinary Studies, Peking University, Beijing 100871,China[5]National Clinical Research Center for Cardiovascular Diseases, FuwaiHospital, National Center for Cardiovascular Diseases, Chinese Academyof Medical Sciences and Peking Union Medical College, Beijing 100871, China[6]Department of Cardiology, Guangdong Cardiovascular Institute, GuangdongProvincial People’s Hospital, Guangdong Academy of Medical Sciences,Guangzhou, China广东省人民医院[7]Department of Cardiology, Qingdao Municipal Hospital,Qingdao, Shandong, China[8]Radiation Oncology Key Laboratory of SichuanProvince, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Schoolof Medicine, University of Electronic Science and Technology of China,Chengdu, China四川省肿瘤医院
Beijing Municipal Science and Technology
Commission (7181008 and Z191100006619106) and the CAMS Innovation
Fund for Medical Sciences (CAMS-I2M, 2016-I2M-1-015).
第一作者机构:[1]Biomedical Pioneering Innovation Center, School of Life Sciences, Ministryof Education Key Laboratory of Cell Proliferation and Differentiation,Beijing 100871, China[3]Beijing Advanced Innovation Center for Genomics, Peking University,Beijing 100871, China[4]Peking‑Tsinghua Center for Life Sciences, Academyfor Advanced Interdisciplinary Studies, Peking University, Beijing 100871,China
共同第一作者:
通讯作者:
通讯机构:[1]Biomedical Pioneering Innovation Center, School of Life Sciences, Ministryof Education Key Laboratory of Cell Proliferation and Differentiation,Beijing 100871, China[2]State Key Laboratory of Cardiovascular Disease, FuwaiHospital, National Center for Cardiovascular Diseases, Chinese Academyof Medical Sciences and Peking Union Medical College, Beijing 100871,China[3]Beijing Advanced Innovation Center for Genomics, Peking University,Beijing 100871, China[5]National Clinical Research Center for Cardiovascular Diseases, FuwaiHospital, National Center for Cardiovascular Diseases, Chinese Academyof Medical Sciences and Peking Union Medical College, Beijing 100871, China
推荐引用方式(GB/T 7714):
Jie Ren,Lin Jiang,Xiaomeng Liu,et al.Heart-specific DNA methylation analysis in plasma for the investigation of myocardial damage.[J].JOURNAL OF TRANSLATIONAL MEDICINE.2022,20(1):doi:10.1186/s12967-022-03234-9.
APA:
Jie Ren,Lin Jiang,Xiaomeng Liu,Yuhan Liao,Xueyan Zhao...&Lei Song.(2022).Heart-specific DNA methylation analysis in plasma for the investigation of myocardial damage..JOURNAL OF TRANSLATIONAL MEDICINE,20,(1)
MLA:
Jie Ren,et al."Heart-specific DNA methylation analysis in plasma for the investigation of myocardial damage.".JOURNAL OF TRANSLATIONAL MEDICINE 20..1(2022)